All in together, our data indicated that RP11-838N2.4 reversed the inhibitory effect of miR-10a on TMZ sensitivity of GBM, at least in part, because of attenuating miR-10a inhibition of EphA8. The gene discussed is EPHA8; the disease is glioblastoma.